Skip to content
Screener

Operating margin at other companies

Gilead Sciences logo
Gilead SciencesGILD
-8.2%-36.1pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-185.4%-83.3pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-242%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
-711.7%-149pp
Allogene Therapeutics logo
Allogene TherapeuticsALLO
-1,241,813.6%-2,018,140pp

Other financials

Income statement

See full
Revenue-
Operating income-$26.9M-17.9%
Net income-$25.0M-17.6%
EPS (diluted)-$0.63+27.6%

Balance sheet

See full
Cash & equivalents$301.9M+944%
Total debt$9.8M-25.5%
Total equity$347.5M+133%
Total assets$368.6M+118%

Cash flow

See full
Operating cash flow-$20.4M+11.4%
CapEx$415.0K-60.7%
Free cash flow-$20.8M+13.6%

Valuation

See full
Market cap$550.99M+783%
Enterprise value$258.93M+455%

Profitability

See full
Net margin-79.3%

Returns & leverage

See full
Return on equity-36.6%
Debt / equity-0.1×
Current ratio24.2×+10.3×

Where this comes from

Calculated from Artiva Biotherapeutics, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2025. Open the filing →

Filed
May 8, 2025
Fiscal quarter
Q1 FY2025
Calendar quarter
Q1 2025
Accession
0000950170-25-066421

FAQ

What is Artiva Biotherapeutics, Inc.'s operating margin?
Artiva Biotherapeutics, Inc. (ARTV) reported operating margin of -83.9% in Q1 2024.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

Ask your AI about Artiva Biotherapeutics, Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude